Nemo-like kinase-myocyte enhancer factor 2A signaling regulates anterior formation in xenopus development

被引:18
|
作者
Satoh, Kiyotoshi
Ohnishi, Junji
Sato, Atsushi
Takeyama, Michio
Iemura, Shun-Ichiro
Natsume, Tohru
Shibuya, Hiroshi [1 ]
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol & Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan
[2] Tokyo Med & Dent Univ, Sch Biomed Sci, Chiyoda Ku, Tokyo 1010062, Japan
[3] JST, SORST, Chiyoda Ku, Tokyo 1010062, Japan
[4] Tokyo Med & Dent Univ, Med Res Inst, Med Top Track Program, Chiyoda Ku, Tokyo 1010062, Japan
[5] Biol Informat Res Ctr JBIRC, Natl Inst Adv Ind Sci & Technol, Kohoku Ku, Tokyo 1350064, Japan
[6] Tokyo Med & Dent Univ, Ctr Excellence Program Res Mol Destruct & Reconst, Chiyoda Ku, Tokyo 1010062, Japan
关键词
D O I
10.1128/MCB.01481-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of anterior neural structure in Xenopus laevis requires the inhibition of bone morphogenic protein 4 and Wnt signaling. We previously reported that Nemo-like kinase (NLK) negatively regulates Wnt signaling via the phosphorylation of T-cell factor/lymphoid enhancer factor. However, the molecular events occurring downstream of NLK pathways in early neural development remain unclear. In the present study, we identified the transcription factor myocyte enhancer factor 2A (MEF2A) as a novel substrate for NLK. NLK regulates the function of Xenopus MEF2A (xMEF2A) via phosphorylation, and this modification can be inhibited by the depletion of endogenous NLK. In Xenopus embryos, the depletion of either NLK or MEF2A results in a severe defect in anterior development. The endogenous expression of anterior markers was blocked by the depletion of endogenous Xenopus NLK (xNLK) or xMEF2A but, notably, not by the depletion of other xMEF2 family proteins, xMEF2C and xMEF2D. Defects in head formation or the expression of the anterior marker genes caused by the depletion of endogenous xMEF2A could be eliminated by the expression of wild-type xMEF2A, but not xMEF2A containing mutated xNLK phosphorylation sites. Furthermore, the expression of xNLK-induced anterior markers was efficiently blocked by the depletion of endogenous xMEF2A in animal pole explants. These results show that NLK specifically regulates the MEF2A activity required for anterior formation in Xenopus development.
引用
收藏
页码:7623 / 7630
页数:8
相关论文
共 32 条
  • [21] Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2
    Sako, Keisuke
    Fukuhara, Shigetomo
    Minami, Takashi
    Hamakubo, Takao
    Song, Haihua
    Kodama, Tatsuhiko
    Fukamizu, Akiyoshi
    Gutkind, J. Silvio
    Koh, Gou Young
    Mochizuki, Naoki
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (09) : 5592 - 5601
  • [22] A p38 Mitogen-Activated Protein Kinase-Regulated Myocyte Enhancer Factor 2-β-Catenin Interaction Enhances Canonical Wnt Signaling
    Ehyai, Saviz
    Dionyssiou, Mathew G.
    Gordon, Joseph W.
    Williams, Declan
    Siu, K. W. Michael
    McDermott, John C.
    MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (02) : 330 - 346
  • [23] Polo-like Kinase 2, a Novel ADAM17 Signaling Component, Regulates Tumor Necrosis Factor ∼ Ectodomain Shedding
    Schwarz, Jeanette
    Schmidt, Stefanie
    Will, Olga
    Koudelka, Tomas
    Koehler, Kaja
    Boss, Melanie
    Rabe, Bjoern
    Tholey, Andreas
    Scheller, Juergen
    Schmidt-Arras, Dirk
    Schwake, Michael
    Rose-John, Stefan
    Chalaris, Athena
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (05) : 3080 - 3093
  • [24] Phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2 (BMP-2)-induced myocyte enhancer factor 2A-dependent transcription of BMP-2 gene in cardiomyocyte precursor cells
    Ghosh-Choudhury, NG
    Abboud, SL
    Mahimainathan, L
    Chandrasekar, B
    Choudhury, GG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (24) : 21998 - 22005
  • [25] IκB Kinase/Nuclear Factor κB-Dependent Insulin-Like Growth Factor 2 (Igf2) Expression Regulates Synapse Formation and Spine Maturation via Igf2 Receptor Signaling
    Schmeisser, Michael J.
    Baumann, Bernd
    Johannsen, Svenja
    Vindedal, Gry F.
    Jensen, Vidar
    Hvalby, Oivind C.
    Sprengel, Rolf
    Seither, Jochen
    Maqbool, Ayesha
    Magnutzki, Alexander
    Lattke, Michael
    Oswald, Franz
    Boeckers, Tobias M.
    Wirth, Thomas
    JOURNAL OF NEUROSCIENCE, 2012, 32 (16): : 5688 - 5703
  • [26] Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle
    Dionyssiou, M. G.
    Nowacki, N. B.
    Hashemi, S.
    Zhao, J.
    Kerr, A.
    Tsushima, R. G.
    McDermott, J. C.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2013, 54 : 35 - 44
  • [27] Autocrine transforming growth factor beta signaling regulates extracellular signal-regulated kinase 1/2 phosphorylation via modulation of protein phosphatase 2A expression in scleroderma fibroblasts
    Samuel, Glady H.
    Bujor, Andreea M.
    Nakerakanti, Sashidhar S.
    Hant, Faye N.
    Trojanowska, Maria
    FIBROGENESIS & TISSUE REPAIR, 2010, 3
  • [28] Myosin Light Chain Kinase Expression Induced via Tumor Necrosis Factor Receptor 2 Signaling in the Epithelial Cells Regulates the Development of Colitis-Associated Carcinogenesis
    Suzuki, Masahiro
    Nagaishi, Takashi
    Yamazaki, Motomi
    Onizawa, Michio
    Watabe, Taro
    Sakamaki, Yuriko
    Ichinose, Shizuko
    Totsuka, Mamoru
    Oshima, Shigeru
    Okamoto, Ryuichi
    Shimonaka, Motoyuki
    Yagita, Hideo
    Nakamura, Tetsuya
    Watanabe, Mamoru
    PLOS ONE, 2014, 9 (02):
  • [29] Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Kruppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin
    Zhao, Ying-Yu
    Zhao, Li-Ni
    Wang, Ping
    Miao, Yin-Sha
    Liu, Yun-Hui
    Wang, Zhen-Hua
    Ma, Jun
    Li, Zhen
    Li, Zhi-Qing
    Xue, Yi-Xue
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (12) : 1891 - 1902
  • [30] TCF7L2(Transcription Factor 7-Like 2) Regulates Activin Receptor-Like Kinase 1(ALK1)/Smad1 Pathway for Development of Diabetic Nephropathy
    Araoka, Toshikazu
    Abe, Hideharu
    Nagai, Kojiro
    Kishi, Fumi
    Tominaga, Tatsuya
    Yoshikawa, Kazuhiro
    Kishi, Seiji
    Murakami, Taichi
    Hirano, Takahiro
    Shigeta, Reiko
    Matsuura, Motokazu
    Mima, Akira
    Takahashi, Toshikazu
    Doi, Toshio
    DIABETES, 2009, 58 : A7 - A7